Journal
NATURE GENETICS
Volume 44, Issue 4, Pages 456-+Publisher
NATURE PORTFOLIO
DOI: 10.1038/ng.2218
Keywords
-
Categories
Funding
- INSERM
- Agence Nationale pour la Recherche (ANR) [05-MRAR-010-01]
- European Union [HEALTH-F4-2007-201550, HEALTH-261123]
- Leducq Foundation (Transatlantic Network on Hypertension) [07 CVD 01]
- Fondation Leducq Trans-Atlantic Network of Excellence [05 CVD 01]
- Groupe de Reflexion sur la Recherche Cardiovasculaire and Biotronik
- Ministry of Science and Innovation (MICINN) [SAF2008-00357]
- MRC [G9521010] Funding Source: UKRI
- Medical Research Council [G9521010] Funding Source: researchfish
Ask authors/readers for more resources
Familial hyperkalemic hypertension (FHHt) is a Mendelian form of arterial hypertension that is partially explained by mutations in WNK1 and WNK4 that lead to increased activity of the Na+-Cl- cotransporter (NCC) in the distal nephron. Using combined linkage analysis and whole-exome sequencing in two families, we identified KLHL3 as a third gene responsible for FHHt. Direct sequencing of 43 other affected individuals revealed 11 additional missense mutations that were associated with heterogeneous phenotypes and diverse modes of inheritance. Polymorphisms at KLHL3 were not associated with blood pressure. The KLHL3 protein belongs to the BTB-BACK-kelch family of actin-binding proteins that recruit substrates for Cullin3-based ubiquitin ligase complexes. KLHL3 is coexpressed with NCC and downregulates NCC expression at the cell surface. Our study establishes a role for KLHL3 as a new member of the complex signaling pathway regulating ion homeostasis in the distal nephron and indirectly blood pressure.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available